|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4752 USD | +3.08% |
|
+2.68% | -10.34% |
BioNexus Gene Lab Corp. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 2.38 million compared to USD 2.38 million a year ago.
Net loss was USD 0.103757 million compared to USD 0.069066 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.34% | 8.4M | |
| +19.41% | 45.51B | |
| -8.62% | 38.52B | |
| +38.65% | 38.13B | |
| +26.95% | 30.74B | |
| -13.50% | 26.03B | |
| +10.74% | 25.92B | |
| +44.87% | 14.13B | |
| +34.36% | 12.73B | |
| -7.14% | 11.29B |
BIONEXUS GENE LAB CORP. 
